Continuous infusion of recombinant interleukin-2 with or without autologous lymphokine activated killer cells for the treatment of advanced renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/1627369

Download in:

View as

General Info

PMID
1627369